Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody Trastuzumab
Alejandro Vázquez‐Martín(Catalan Institute for Water Research), Javier A. Menéndez(Catalan Institute for Water Research)
Cited by 245
Related Papers
The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells
|Cell Cycle|2009|251
Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental Validation
|Frontiers in Endocrinology|2018|122